Singapore markets closed

Ondine Biomedical Inc. (OBI.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
7.500.00 (0.00%)
At close: 03:49PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
804
638
2,569
1,791
464
Cost of revenue
410
351
1,315
1,142
328
Gross profit
394
287
1,254
649
136
Operating expenses
Research development
5,823
6,280
4,982
3,309
3,422
Selling general and administrative
12,427
12,310
13,334
12,039
9,554
Total operating expenses
18,781
19,050
18,774
16,520
14,164
Operating income or loss
-18,387
-18,763
-17,520
-15,871
-14,028
Interest expense
41
30
1,212
491
179
Income before tax
-18,702
-19,372
-50,085
-16,271
-13,990
Income tax expense
-
-
0
0
-
Income from continuing operations
-18,702
-19,372
-50,085
-16,271
-13,990
Net income
-18,702
-19,372
-50,085
-16,271
-13,985
Net income available to common shareholders
-18,702
-19,372
-50,085
-16,271
-13,985
Basic EPS
-0.10
-0.10
-0.63
-0.08
-0.07
Diluted EPS
-0.10
-0.10
-0.63
-0.08
-0.07
Basic average shares
194,654
194,588
79,638
194,585
194,585
Diluted average shares
194,654
194,588
79,638
194,585
194,585